ERBB2 and neoplasm: The ability of 10AT-Her2 cells to form tumor xenografts in vivo is tenfold more efficient than that reported for highly tumorigenic human breast cancer cell lines such as MCF-7, MDA-MB-231 and SKBR3, which require approximately 2 million cells for tumor xenografts to be observed [52].